James B Johnston
Overview
Explore the profile of James B Johnston including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
1237
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kost S, Saleh A, Brown J, Yuan S, Kuzio B, Yang Dr L, et al.
Blood Adv
. 2025 Feb;
PMID: 39969198
No abstract available.
2.
Manivannan M, Yang X, Patel N, Peters A, Johnston J, Gibson S
Cells
. 2024 Jun;
13(12.
PMID: 38920669
Venetoclax and obinutuzumab are becoming frontline therapies for chronic lymphocytic leukemia (CLL) patients. Unfortunately, drug resistance still occurs, and the combination could be immunosuppressive. Lysosomes have previously been identified as...
3.
Grever M, Andritsos L, Anghelina M, Arons E, Banerji V, Barrientos J, et al.
Leukemia
. 2024 Jun;
38(7):1642-1644.
PMID: 38851853
No abstract available.
4.
5.
Yang J, Yang L, Tordon B, Bucher O, Nugent Z, Landego I, et al.
Curr Oncol
. 2023 Jul;
30(7):6411-6431.
PMID: 37504332
FISH cytogenetics, TP53 sequencing, and IGHV mutational status are increasingly used as prognostic and predictive markers in chronic lymphocytic leukemia (CLL), particularly as components of the CLL International Prognostic Index...
6.
Wu X, Thisdelle J, Hou S, Fajardo-Despaigne J, Gibson S, Johnston J, et al.
Leuk Res
. 2023 Jun;
131:107315.
PMID: 37263073
Interleukin-16 (IL-16) is a novel biomarker that has been implicated in many cancers as well as inflammatory diseases. In this study, we examined plasma levels of 30 cytokines and chemokines...
7.
8.
Choquette T, Henson E, Yang X, Johnston J, Gibson S
Leuk Lymphoma
. 2023 Feb;
64(4):822-834.
PMID: 36803637
Microenvironments such as lymph nodes allow chronic lymphocytic leukemia (CLL) cells to survive and become drug resistant. There are limited methods to study the to study the contribution of the...
9.
Kost S, Saleh A, Yuan S, Kuzio B, Gibson S, Yang L, et al.
Blood Cancer J
. 2023 Jan;
13(1):20.
PMID: 36707503
No abstract available.
10.
Ravandi F, Kreitman R, Tiacci E, Andritsos L, Banerji V, Barrientos J, et al.
Blood Cancer J
. 2022 Dec;
12(12):165.
PMID: 36509740
A significant body of literature has been generated related to the detection of measurable residual disease (MRD) at the time of achieving complete remission (CR) in patients with hairy cell...